In a meta-analysis studying the effect of carbetocin on PPH prevention, carbetocin required fewer additional drugs to treat PPH, with less blood loss than syntometrine, making it a promising alternative to oxytocin [14]. This evidence concerns the gene OXT and pulmonary arterial hypertension.